Medicare Enrolled

Dr. Dan Steinfink, MD

Psychiatry · Plano, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
5300 W PLANO PKWY STE 100, Plano, TX 75093
9727337242
Registered in NPPES since 2006
NPI: 1144295296 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Steinfink from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Steinfink? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Steinfink

Dr. Dan Steinfink is a psychiatry specialist in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Steinfink performed 710 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Steinfink received a total of $7,740 from 43 pharmaceutical and/or device companies across 394 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Steinfink is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 14% volume in TX $7,740 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
710
Medicare services
Top 14% in TX for psychiatry
Not available
Unique patients (not deduplicated)
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
357 $139 $513
Assessment of emotional or behavioral problems
An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns.
152 $3 $25
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
148 $66 $300
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
29 $50 $200
Magnetic field treatment to stimulate brain nerve cells, initial delivery
A procedure that uses a magnetic field to stimulate nerve cells in the brain. This code covers the initial delivery and management of the treatment.
13 $157 $650
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
11 $120 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,740
Total received (2018-2024)
Avg $1,106/year across 7 years
Top 9% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
394
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,708
2023
$1,556
2022
$1,493
2021
$2,044
2020
$58
2019
$341
2018
$540

Payments by company (2024)

Otsuka America Pharmaceutical, Inc.
$203
ABBVIE INC.
$202
Neurocrine Biosciences, Inc.
$188
Corium, LLC
$172
Janssen Pharmaceuticals, Inc
$153
Takeda Pharmaceuticals U.S.A., Inc.
$140
Vanda Pharmaceuticals Inc.
$103
Lundbeck LLC
$103
Teva Pharmaceuticals USA, Inc.
$95
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$78
Axsome Therapeutics, Inc.
$74
Almatica Pharma LLC
$72
Noven Therapeutics, LLC
$71
Eisai Inc.
$24
Itamar Medical Inc
$16
Validus Pharmaceuticals LLC
$16
Top 3 companies account for 34.7% of 2024 payments
All-time payments by company (2018-2024) ›
Validus Pharmaceuticals LLC
$958
Otsuka America Pharmaceutical, Inc.
$896
Takeda Pharmaceuticals U.S.A., Inc.
$594
AbbVie Inc.
$541
ABBVIE INC.
$439
Lundbeck LLC
$436
Janssen Pharmaceuticals, Inc
$374
Corium, LLC
$338
Vanda Pharmaceuticals Inc.
$337
Almatica Pharma LLC
$243
Teva Pharmaceuticals USA, Inc.
$224
Neurocrine Biosciences, Inc.
$214
ITI, Inc.
$200
Axsome Therapeutics, Inc.
$155
Bausch Health US, LLC
$135
Ironshore Pharmaceuticals Inc.
$129
Allergan Inc.
$127
JAZZ PHARMACEUTICALS INC.
$127
Shire North American Group Inc
$124
Alkermes, Inc.
$116
Merck Sharp & Dohme LLC
$105
Noven Therapeutics, LLC
$103
Vertical Pharmaceuticals, LLC
$89
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$78
Avanir Pharmaceuticals, Inc.
$77
Tris Pharma Inc
$74
Alfasigma USA, Inc.
$58
Supernus Pharmaceuticals, Inc.
$57
Eisai Inc.
$48
IDORSIA PHARMACEUTICALS US INC
$41
Adlon Therapeutics L.P.
$40
GE HEALTHCARE
$36
Neos Therapeutics, LP
$35
Lilly USA, LLC
$35
Allergan, Inc.
$26
Noven Pharmaceuticals, Inc.
$24
Merck Sharp & Dohme Corporation
$20
EISAI INC.
$20
BioXcel Therapeutics, Inc.
$19
Itamar Medical Inc
$16
Neuronetics, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$13
Sunovion Pharmaceuticals Inc.
$7
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · AMYVID · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adlarity · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · CAPLYTA · COTEMPLA XR-ODT · DIVIGEL · Dayvigo · Dyanavel XR · Equetro · Evekeo · Fanapt · GRALISE · HETLIOZ · IGALMI · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · Leqembi · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · Nuedexta · QELBREE · QUVIVIQ · RELEXXII · REXULTI · SECUADO · SPRAVATO · SUNOSI · Secuado · Sunosi · TRINTELLIX · Trintellix · UZEDY · VRAYLAR · VYVANSE · WELLBUTRIN · WatchPATONE · XYREM · Xelstrym
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Plano?
Compare psychiatrists in the Plano area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
588
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Steinfink is a clinical cardiology specialist, with above-average Medicare volume (top 14% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Steinfink experienced with magnetic field treatment to stimulate brain nerve cells?
Based on Medicare claims data, Dr. Steinfink performed 357 magnetic field treatment to stimulate brain nerve cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Steinfink receive payments from pharmaceutical companies?
Yes. Dr. Steinfink received a total of $7,740 from 43 companies across 394 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Steinfink's costs compare to other psychiatrists in Plano?
Dr. Steinfink's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Steinfink) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →